Edgewise Therapeutics
EWTX
EWTX
31 hedge funds and large institutions have $1.48B invested in Edgewise Therapeutics in 2021 Q1 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+31
Holders Change %
–
% of All Funds
0.55%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
%
% of All Funds
0.09%
New
31
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$453M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$182M |
| 3 |
DM
Deerfield Management
New York
|
+$128M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$109M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$84.9M |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Millennium Management
New York
| $1.95M | +$1.95M | +60,077 | New |
|
27
BlackRock
New York
| $1.8M | +$1.8M | +55,485 | New |
|
|
CCM
28
CAAS Capital Management
New York
| $975K | +$975K | +30,000 | New |
|
29
Squarepoint
New York
| $656K | +$656K | +20,185 | New |
|
|
LCM
30
Landscape Capital Management
Englewood,
New Jersey
| $290K | +$290K | +8,923 | New |
|
|
MS
31
Maven Securities
St Helier,
Jersey
| $262K | +$262K | +8,300 | New |
|